OBJECTIVES: To evaluate the efficacy and safety of purine analogs (azathioprine, 6-mercaptopurine (6-MP)) in the prevention of postoperative recurrence in Crohn's disease (CD).METHODS:We searched MEDLINE, the Cochrane Library, and EMBASE. The primary end points, clinical and endoscopic recurrence at 1 and 2 years, and safety were analyzed by the methods of Peto and Der Simonian and Laird.RESULTS:Four controlled trials enrolled 433 patients and compared azathioprine (n3) or (6-MP) (n1) with control arms (placebo with or without antibiotic induction therapy or mesalamine). In the overall analysis, purine analogs were more effective than control arms in preventing clinical recurrence at 1 year (mean difference, 95% confidence interval (CI): 8, 1-15%, P0.021, number needed to treat (NNT)13) and 2 years (mean difference, 95% CI: 13%, 2-24%, P0.018, NNT8). In sensitivity analyses, the efficacy of purine analogs was superior to that of placebo for the prevention of clinical and endoscopic recurrence at 1 year (mean differences, 95% CI: 13, 1.8-25%, P0.025, NNT7, and 23%, 9-37%, P0.0016, NNT4, respectively). At 1 year, in the overall analysis, purine analogs were more effective than control arms were in preventing severe (i2-4) endoscopic recurrence (mean difference, CI 95%: 15, 1.8-29%, P0.026, NNT7), but they were not effective in the prevention of very severe (i3-4) recurrence. The rate of adverse events leading to drug withdrawal was higher in thiopurine-treated patients than in control arms (17.2 vs. 9.8%, respectively, P0.021).CONCLUSIONS:Purine analogs are more effective than placebo in preventing both clinical and endoscopic postoperative recurrence in CD, but they are associated with a higher rate of adverse events leading to drug withdrawal.

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease : a meta-analysis / L. Peyrin-Biroulet, P. Deltenre, S. Ardizzone, G. D'Haens, S.B. Hanauer, H. Herfarth, M. Lémann, J. Colombel. - In: THE AMERICAN JOURNAL OF GASTROENTEROLOGY. - ISSN 0002-9270. - 104:8(2009 Aug), pp. 2089-2096. [10.1038/ajg.2009.301]

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease : a meta-analysis

S. Ardizzone;
2009

Abstract

OBJECTIVES: To evaluate the efficacy and safety of purine analogs (azathioprine, 6-mercaptopurine (6-MP)) in the prevention of postoperative recurrence in Crohn's disease (CD).METHODS:We searched MEDLINE, the Cochrane Library, and EMBASE. The primary end points, clinical and endoscopic recurrence at 1 and 2 years, and safety were analyzed by the methods of Peto and Der Simonian and Laird.RESULTS:Four controlled trials enrolled 433 patients and compared azathioprine (n3) or (6-MP) (n1) with control arms (placebo with or without antibiotic induction therapy or mesalamine). In the overall analysis, purine analogs were more effective than control arms in preventing clinical recurrence at 1 year (mean difference, 95% confidence interval (CI): 8, 1-15%, P0.021, number needed to treat (NNT)13) and 2 years (mean difference, 95% CI: 13%, 2-24%, P0.018, NNT8). In sensitivity analyses, the efficacy of purine analogs was superior to that of placebo for the prevention of clinical and endoscopic recurrence at 1 year (mean differences, 95% CI: 13, 1.8-25%, P0.025, NNT7, and 23%, 9-37%, P0.0016, NNT4, respectively). At 1 year, in the overall analysis, purine analogs were more effective than control arms were in preventing severe (i2-4) endoscopic recurrence (mean difference, CI 95%: 15, 1.8-29%, P0.026, NNT7), but they were not effective in the prevention of very severe (i3-4) recurrence. The rate of adverse events leading to drug withdrawal was higher in thiopurine-treated patients than in control arms (17.2 vs. 9.8%, respectively, P0.021).CONCLUSIONS:Purine analogs are more effective than placebo in preventing both clinical and endoscopic postoperative recurrence in CD, but they are associated with a higher rate of adverse events leading to drug withdrawal.
6-mercaptopurine; azathioprine; Crohn disease; humans; immunosuppressive agents; recurrence; gastroenterology
Settore MED/12 - Gastroenterologia
ago-2009
Article (author)
File in questo prodotto:
File Dimensione Formato  
Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn’s Disease- A Meta-Analysis.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 191.92 kB
Formato Adobe PDF
191.92 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/515900
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus 223
  • ???jsp.display-item.citation.isi??? 304
social impact